439 related articles for article (PubMed ID: 15661802)
1. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
2. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
3. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
Gong M; Lu Z; Fang G; Bi J; Xue X
Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation.
Wai PY; Guo L; Gao C; Mi Z; Guo H; Kuo PC
Surgery; 2006 Aug; 140(2):132-40. PubMed ID: 16904962
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
Wang ZM; Cui YH; Li W; Chen SY; Liu TS
Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
[TBL] [Abstract][Full Text] [Related]
6. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Liu H; Chen A; Guo F; Yuan L
Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
[TBL] [Abstract][Full Text] [Related]
8. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
[TBL] [Abstract][Full Text] [Related]
9. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
[TBL] [Abstract][Full Text] [Related]
10. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion.
Philip S; Bulbule A; Kundu GC
Glycoconj J; 2004; 21(8-9):429-41. PubMed ID: 15750784
[TBL] [Abstract][Full Text] [Related]
12. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.
Du XL; Jiang T; Sheng XG; Gao R; Li QS
Gynecol Oncol; 2009 Dec; 115(3):371-6. PubMed ID: 19783287
[TBL] [Abstract][Full Text] [Related]
14. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Georges R; Adwan H; Zhivkova M; Eyol E; Bergmann F; Berger MR
Int J Oncol; 2010 Aug; 37(2):249-56. PubMed ID: 20596651
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
[TBL] [Abstract][Full Text] [Related]
16. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells.
Kitakata H; Nemoto-Sasaki Y; Takahashi Y; Kondo T; Mai M; Mukaida N
Cancer Res; 2002 Nov; 62(22):6682-7. PubMed ID: 12438267
[TBL] [Abstract][Full Text] [Related]
17. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
[TBL] [Abstract][Full Text] [Related]
18. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
[TBL] [Abstract][Full Text] [Related]
19. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
20. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
